Skip to main content

Table 8 The cumulative ten years cost - effectiveness and cost – benefit of sif in montreal using the Jacobs et al.[18] model

From: A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Montreal, Canada

Variables

Annual cost of operation

# of HIV averted

# of HCV averted

Cost-effectiveness ratio HCV

Cost-effectiveness ratio HIV

Cost-benefit ratio HCV

Cost-benefit ratio HIV

Post SIF

$21,828,000

140

840

$25,986

$155,914

1.35

1.35

Two SIF

$43,656,000

260

1620

$26,948

$167,908

1.25

1.25

Three SIF

$65,484,000

320

1950

$33,582

$204,637

1.03

1.03

Four SIF

$87,312,000

370

2270

$38,463

$235,978

0.89

0.89

Five SIF

$109,140,000

430

2610

$41,816

$253,814

0.83

0.83

Six SIF

$130,968,000

480

2940

$44,547

$272,850

0.77

0.77

Seven SIF

$152,796,000

530

3270

$46,727

$288,294

0.73

0.73

Average

$87,312,000

360

2210

$39,508

$242,533

0.87

0.87